Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 2
2006 1
2010 1
2011 2
2012 1
2013 2
2016 2
2021 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

12 results
Results by year
Filters applied: . Clear all
Page 1
Proteomic classification of breast cancer.
Kamel D, Brady B, Tabchy A, Mills GB, Hennessy B. Kamel D, et al. Among authors: tabchy a. Curr Drug Targets. 2012 Nov;13(12):1495-509. doi: 10.2174/138945012803530080. Curr Drug Targets. 2012. PMID: 22974393 Review.
Quantitative proteomic analysis in breast cancer.
Tabchy A, Hennessy BT, Gonzalez-Angulo AM, Bernstam FM, Lu Y, Mills GB. Tabchy A, et al. Drugs Today (Barc). 2011 Feb;47(2):169-82. doi: 10.1358/dot.2011.47.2.1576695. Drugs Today (Barc). 2011. PMID: 21431104
Evaluation of a 30-gene paclitaxel, fluorouracil, doxorubicin, and cyclophosphamide chemotherapy response predictor in a multicenter randomized trial in breast cancer.
Tabchy A, Valero V, Vidaurre T, Lluch A, Gomez H, Martin M, Qi Y, Barajas-Figueroa LJ, Souchon E, Coutant C, Doimi FD, Ibrahim NK, Gong Y, Hortobagyi GN, Hess KR, Symmans WF, Pusztai L. Tabchy A, et al. Clin Cancer Res. 2010 Nov 1;16(21):5351-61. doi: 10.1158/1078-0432.CCR-10-1265. Epub 2010 Sep 9. Clin Cancer Res. 2010. PMID: 20829329 Free PMC article. Clinical Trial.
[89Zr]Trastuzumab: Evaluation of Radiation Dosimetry, Safety, and Optimal Imaging Parameters in Women with HER2-Positive Breast Cancer.
Laforest R, Lapi SE, Oyama R, Bose R, Tabchy A, Marquez-Nostra BV, Burkemper J, Wright BD, Frye J, Frye S, Siegel BA, Dehdashti F. Laforest R, et al. Among authors: tabchy a. Mol Imaging Biol. 2016 Dec;18(6):952-959. doi: 10.1007/s11307-016-0951-z. Mol Imaging Biol. 2016. PMID: 27146421 Free PMC article. Clinical Trial.
12 results